Orthologue selectivity and ligand bias: Translating the pharmacology of GPR35

Trends in Pharmacological Sciences

Volumn 32, Issue 5, 2011, Pages 317-325

  Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; CID 2745687; CROMOGLYCATE DISODIUM; DICOUMAROL; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 35; KYNURENIC ACID; LUTEOLIN; OXANTEL EMBONATE; RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG; ZAPRINAST;

5' UNTRANSLATED REGION; ARTERY CALCIFICATION; ASTHMA; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG RECEPTOR BINDING; DRUG TARGETING; ENTERITIS; G PROTEIN COUPLED RECEPTOR 35 GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HYPERTENSION; NONHUMAN; PAIN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SEQUENCE; ANIMALS; ASTHMA; DIABETES MELLITUS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; HYPERTENSION; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; SPECIES SPECIFICITY;

EID: 79955738004     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2011.02.002     Document Type: Review

References (53)

1. B.F. O'Dowd Discovery of three novel G-protein-coupled receptor genes Genomics 47 1998 310 313 (Pubitemid 28086858)
2. S. Okumura Cloning of a G-protein-coupled receptor that shows an activity to transform NIH3T3 cells and is expressed in gastric cancer cells Cancer Sci. 95 2004 131 135 (Pubitemid 38404313)
3. A.E. Shrimpton Molecular delineation of deletions on 2q37.3 in three cases with an Albright hereditary osteodystrophy-like phenotype Clin. Genet. 66 2004 537 544 (Pubitemid 39562017)
4. Y. Horikawa Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus Nat. Genet. 26 2000 163 175
5. J. Guo Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons J. Pharmacol. Exp. Ther. 324 2008 342 351 (Pubitemid 350294182)
6. Y.V. Sun Application of machine learning algorithms to predict coronary artery calcification with a sibship-based design Genet. Epidemiol. 32 2008 350 360 (Pubitemid 351656306)
7. M. Imielinski Common variants at five new loci associated with early-onset inflammatory bowel disease Nat. Genet. 41 2009 1335 1340
8. J. Wang Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 J. Biol. Chem. 281 2006 22021 22028 (Pubitemid 44181906)
9. G. Milligan, and E. Kostenis Heterotrimeric G-proteins: a short history Br. J. Pharmacol. 147 Suppl. 1 2006 S46 55
10. E. Kostenis Techniques: promiscuous Gα proteins in basic research and drug discovery Trends Pharmacol. Sci. 26 2005 595 602 (Pubitemid 41505228)
11. H. Ohshiro GPR35 is a functional receptor in rat dorsal root ganglion neurons Biochem. Biophys. Res. Commun. 365 2008 344 348 (Pubitemid 350137295)
12. P. Zhao Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity Mol. Pharmacol. 78 2010 560 568
13. L. Jenkins Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα(13) and β-arrestin-2 Br. J. Pharmacol. 162 2011 733 748
14. S. Oka GPR35 is a novel lysophosphatidic acid receptor Biochem. Biophys. Res. Commun. 395 2010 232 237
15. D. Kuc Micromolar concentration of kynurenic acid in rat small intestine Amino Acids 35 2008 503 505
16. J. Chun International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature Pharmacol. Rev. 62 2010 579 587
17. G. Tigyi Aiming drug discovery at lysophosphatidic acid targets Br. J. Pharmacol. 161 2010 241 270
18. K. Noguchi Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family J. Biol. Chem. 278 2003 25600 25606 (Pubitemid 36835313)
19. H. Sharir, and M.E. Abood Pharmacological characterization of GPR55, a putative cannabinoid receptor Pharmacol. Ther. 126 2010 301 313
20. S. Oka Identification of GPR55 as a lysophosphatidylinositol receptor Biochem. Biophys. Res. Commun. 362 2007 928 934 (Pubitemid 47390663)
21. S. Ishii Non-Edg family lysophosphatidic acid (LPA) receptors Prostaglandins Other Lipid Mediat. 89 2009 57 65
22. Y. Taniguchi Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35 FEBS Lett. 580 2006 5003 5008 (Pubitemid 44332369)
23. 13 Biochem. J. 432 2010 451 459
24. R.R. Neubig Mind your salts: when the inactive constituent isn't Mol. Pharmacol. 78 2010 558 559
25. Leonard, J. et al. Arena Pharmaceuticals Inc.GPR35 and modulators thereof for the treatment of metabolic-related disorders, WO 2005/119252 A2.
26. C. Liu Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81 J. Biol. Chem. 284 2009 2811 2822
27. J.A. Ballesteros, and H. Weinstein Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors Methods Neurosci. 25 1995 366 428
28. 35S]GTPγS and Eu-GTPγS) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors Br. J. Pharmacol. 161 2010 1238 1249
29. 35S]GTPγS binding assays Trends Pharmacol. Sci. 24 2003 87 90 (Pubitemid 36135882)
30. T. Worzfeld G(12)/G(13)-mediated signalling in mammalian physiology and disease Trends Pharmacol. Sci. 29 2008 582 589
31. S. Fallarini Expression of functional GPR35 in human iNKT cells Biochem. Biophys. Res. Commun. 398 2010 420 425
32. C. Cosi G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast Neuropharmacology 2010 10.1016/j.neuropharm.201011.014
33. Y. Yang G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium Pharmacology 86 2010 1 5
34. M.C. Barth Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions J. Biol. Chem. 284 2009 19189 19195
35. L. Sparfel Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene Toxicol. Sci. 114 2010 247 259
36. S. Edfalk Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion Diabetes 57 2008 2280 2287
37. A. Ichimura Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis Prostaglandins Other Lipid. Mediat. 89 2009 82 88
38. K.D. Min Identification of genes related to heart failure using global gene expression profiling of human failing myocardium Biochem. Biophys. Res. Commun. 393 2010 55 60
39. E. Kostenis G proteins in drug screening: from analysis of receptor-G protein specificity to manipulation of GPCR-mediated signalling pathways Curr. Pharm. Des. 12 2006 1703 1715
40. R. Emkey, and N.B. Rankl Screening G protein-coupled receptors: measurement of intracellular calcium using the fluorometric imaging plate reader Methods Mol. Biol. 565 2009 145 158
41. K. Liu A multiplex calcium assay for identification of GPCR agonists and antagonists Assay Drug Dev. Technol. 8 2010 367 379
42. T. Ueda Development of generic calcium imaging assay for monitoring Gi-coupled receptors and G-protein interaction J. Biomol. Screen. 14 2009 781 788
43. S.H. Hsu, and C.W. Luo Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs Am. J. Physiol. Endocrinol. Metab. 293 2007 E1021 E1029
44. S.J. Dowell, and A.J. Brown Yeast assays for G protein-coupled receptors Methods Mol. Biol. 552 2009 213 229
45. L.M. Luttrell, and D. Gesty-Palmer Beyond desensitization: physiological relevance of arrestin-dependent signaling Pharmacol. Rev. 62 2010 305 330
46. S.M. DeWire Beta-arrestins and cell signaling Annu. Rev. Physiol. 69 2007 483 510
47. F. Verkaar G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors Biotechnol. Annu. Rev. 14 2008 253 274 (Pubitemid 351916584)
48. R.J. Garippa High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec Opera Methods Enzymol. 414 2006 99 120 (Pubitemid 44716219)
49. D. Haasen Comparison of G-protein coupled receptor desensitization- related beta-arrestin redistribution using confocal and non-confocal imaging Comb. Chem. High Throughput Screen. 9 2006 37 47
50. R.M. Eglen Assessing GPCR activation using protein complementation: a novel technique for HTS Biochem. Soc. Trans. 35 2007 746 748 (Pubitemid 47310359)
51. M. Kocan, and K.D. Pfleger Detection of GPCR/beta-arrestin interactions in live cells using bioluminescence resonance energy transfer technology Methods Mol. Biol. 552 2009 305 317
52. J.D. Violin, and R.J. Lefkowitz Beta-arrestin-biased ligands at seven-transmembrane receptors Trends Pharmacol. Sci. 28 2007 416 422
53. T. Kenakin Functional selectivity and biased receptor signaling J. Pharmacol. Exp. Ther. 2010 10.1124/jpet.110.173948